Back
Cardiff Oncology Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
58
CRDF
Cardiff Oncology
Last Price:
$4.06
Seasonality Move:
13.5%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing selling pressure, which indicates risk of future bearish movement.
Cardiff Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.83 | Buy |
20-day SMA: | 3.54 | Buy |
50-day SMA: | 3.27 | Buy |
200-day SMA: | 3.35 | Buy |
8-day EMA: | 3.86 | Buy |
20-day EMA: | 3.63 | Buy |
50-day EMA: | 3.26 | Buy |
200-day EMA: | 1.75 | Buy |
Cardiff Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 65.56 | Buy |
Chaikin Money Flow: | -473974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.24 - 4) | Buy |
Bollinger Bands (100): | (2.8 - 3.98) | Buy |
Cardiff Oncology Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cardiff Oncology Stock
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 4.07 while CRDF 8-day simple moving average is 3.83, which is a Buy signal.
-
The stock price of CRDF is 4.07 while Cardiff Oncology 20-day SMA is 3.54, which makes it a Buy.
-
Cardiff Oncology 50-day simple moving average is 3.27 while CRDF share price is 4.07, making it a Buy technically.
-
CRDF stock price is 4.07 and Cardiff Oncology 200-day simple moving average is 3.35, creating a Buy signal.
CRDF Technical Analysis vs Fundamental Analysis
Buy
58
Cardiff Oncology (CRDF)
is a Buy
Is Cardiff Oncology a Buy or a Sell?
-
Cardiff Oncology stock is rated a BuyThe current Cardiff Oncology [CRDF] share price is $4.07. The Score for CRDF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Cardiff Oncology Stock Info
Market Cap:
270.8M
Price in USD:
4.07
Share Volume:
886.1K
Cardiff Oncology 52-Week Range
52-Week High:
5.64
52-Week Low:
2.01
Buy
58
Cardiff Oncology (CRDF)
is a Buy
Cardiff Oncology Share Price Forecast
-
What is the Cardiff Oncology stock price today?The Cardiff Oncology stock price is 4.07 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology is not overvalued.
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 4.07 while CRDF 8-day exponential moving average is 3.86, which is a Buy signal.
-
The stock price of CRDF is 4.07 while Cardiff Oncology 20-day EMA is 3.63, which makes it a Buy.
-
Cardiff Oncology 50-day exponential moving average is 3.26 while CRDF share price is 4.07, making it a Buy technically.
-
CRDF stock price is 4.07 and Cardiff Oncology 200-day simple moving average is 1.75, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology
Is Cardiff Oncology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.17 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Cardiff Oncology
Should I short Cardiff Oncology stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Cardiff Oncology is a Buy
-
Cardiff Oncology Relative Strength Index (RSI) is 65.56, which suggest Cardiff Oncology is overbought
-
The Bollinger Bands (25) for Cardiff Oncology is (3.24 - 4), which suggest Cardiff Oncology is a Buy
-
The Bollinger Bands (100) for Cardiff Oncology is (2.8 - 3.98), which suggest Cardiff Oncology is a Buy
* Cardiff Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.